Definitive reviews on approaches to the management of neurological and psychiatric illnesses. Disease management reviews providing practical recommendations for specific clinical situations. Adis Drug Evaluations reviewing the properties and place in disease management of both newer and established drugs. Adis New Drug Profiles with expert commentary. Original research articles will also be considered for publication.
All manuscripts are subject to peer review by international experts.
Letters to the Editor are welcomed and will be considered for publication. A free sample issue of this journal is available either online or a free print copy may be requested . In addition to an Editorial Board comprised of internationally acknowledged experts in their fields, the Journal has an extensive peer-review panel, ensuring that all manuscripts meet the high standards expected of CNS Drugs . An acknowledgement of this panel can be found in the December issue of the Journal. Instructions for Authors Articles in CNS Drugs are either commissioned from leading international experts, or are written by Adis' own staff of experienced medical writers.